Press release


Powered by ChronoForms -

Main purpose of this partnership is to improve scientific and methodological principles of drug safety monitoring and develop effective algorithms for analyzing pharmacotherapy risk. The result of cooperation will be the development of scientific and methodological principles for the creation of integrated decision support systems in the field of rational pharmacotherapy.


One of the main tasks of the "Strategy of drug provision for the population of the Russian Federation for the year 2025" is to ensure the safety, efficacy and quality of medicines. Nowadays, this problem is especially important because of the single market for medicinal products for medical use in the EAEU countries implementation, as well as start of using the results of medicines interchangeability in Russia since 2018. One of the Strategy objectives is introduction of an electronic medicines prescribing system with possibility of their integration with decision support systems. Development of effective algorithms for the analysis of pharmacotherapy risk will facilitate scientifically based selection of rational pharmacotherapy in such systems and will contribute to the implementation of the Strategy objectives. Meanwhile it’s important to solve the problem of improving methodology for identifying and assessing safety signal of medicinal products, because of new documents regulating the circulation of medicines in the EAEU and the expected increase in the volume of information on the drugs safety. Thus, development and improvement of scientific and methodological principles of drug safety evaluation and development of effective algorithms for the pharmacotherapy risk analysis is a major scientific problem of great importance for the public health development.


Flex Databases team appreciates Government Regulator's attention and is grateful for the high evaluation of the software by the Scientific Center representatives. Scientific Center has already recommended Flex Databases module for pharmacovigilance at a number of meetings and conferences. The ability to work with the regulator on the pharmacovigilance system is of great importance for Flex Databases.


You can find out more about Flex Databases Pharmacovigilance system here or contact us for a demo.

You may also be interested in
Flex Databases is always ready to support you in any challenging situation. And today, when GDPR came into effect, we are here to demonstrate that with us you are fully prepared to it in terms of our...
Clinical Trials are notoriously expensive to operate, with the majority of trial sites working with no more than a 3-month operating budget. That means that maintaining up-to-date financial records, a...
The past few years have created something of a boom in the development of Blockchain technology and its emerging applications within various industries and spheres of life. Following our strategic pol...
Last week Timur Galimov, our Chief Technology Officer, and Olga Sokolova, System Analysis Director, conducted a 2-day training for our client Novo Nordisk, a global healthcare company with more than 9...


DIABIOIPhEBCTMSEDCLMSe-CRFFDACROquizFlex JournalpharmacovigilanceinfographicGCPSCOPE

Powered by ChronoForms -

Request Demo

Get in touch for a demo of our system. Fill in the form and we’ll contact you to demonstrate the system in action.

Powered by ChronoForms -

Ваша заявка отправлена

Спасибо за Ваш интерес! Вы подписаны на нашу новостную рассылку.

Your request send

Thank you for your interest! You are subscribed to our newsletter